# FDA Inspection 817920 - Texas Oncology, P.A. - Allison Cancer Center - February 11, 2013

Source: https://www.keypedia.com/records/fda_inspections/texas-oncology-pa-allison-cancer-center/69a4c834-43f1-4a76-9ef4-02a7849d7bbd
Source feed: FDA_Inspections

> FDA Inspection 817920 for Texas Oncology, P.A. - Allison Cancer Center on February 11, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 817920
- Company Name: Texas Oncology, P.A. - Allison Cancer Center
- Inspection Date: 2013-02-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 710590 - 2011-02-01](https://www.keypedia.com/records/fda_inspections/texas-oncology-pa-allison-cancer-center/1afe94c8-bf7d-4ed7-8aab-c88838f97b65)

Company: https://www.keypedia.com/companies/texas-oncology-pa-allison-cancer-center/31e8ff9a-304b-4554-a7aa-f8748f70430e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d